155 related articles for article (PubMed ID: 25492570)
21. Activation of hypoxia-inducible factor 1 in human T-cell leukaemia virus type 1-infected cell lines and primary adult T-cell leukaemia cells.
Tomita M; Semenza GL; Michiels C; Matsuda T; Uchihara JN; Okudaira T; Tanaka Y; Taira N; Ohshiro K; Mori N
Biochem J; 2007 Sep; 406(2):317-23. PubMed ID: 17576198
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia Enhances Proliferation of Human Adipose-Derived Stem Cells via HIF-1ɑ Activation.
Kakudo N; Morimoto N; Ogawa T; Taketani S; Kusumoto K
PLoS One; 2015; 10(10):e0139890. PubMed ID: 26465938
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
Knowles HJ; Athanasou NA
J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716
[TBL] [Abstract][Full Text] [Related]
24. The HIF-2alpha dependent induction of PAP and adenosine synthesis regulates glioblastoma stem cell function through the A2B adenosine receptor.
Liu TZ; Wang X; Bai YF; Liao HZ; Qiu SC; Yang YQ; Yan XH; Chen J; Guo HB; Zhang SZ
Int J Biochem Cell Biol; 2014 Apr; 49():8-16. PubMed ID: 24434023
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia induces late preconditioning in the rat heart in vivo.
Berger MM; Huhn R; Oei GT; Heinen A; Winzer A; Bauer I; Preckel B; Weber NC; Schlack W; Hollmann MW
Anesthesiology; 2010 Dec; 113(6):1351-60. PubMed ID: 21068657
[TBL] [Abstract][Full Text] [Related]
26. Silencing of hypoxia inducible factor-1alpha by RNA interference attenuates human glioma cell growth in vivo.
Gillespie DL; Whang K; Ragel BT; Flynn JR; Kelly DA; Jensen RL
Clin Cancer Res; 2007 Apr; 13(8):2441-8. PubMed ID: 17438103
[TBL] [Abstract][Full Text] [Related]
27. Prolonged attenuation of acetylcholine-induced phosphorylation of extracellular signal-regulated kinase 1/2 following sevoflurane exposure.
Wiklund A; Gustavsson D; Ebberyd A; Sundman E; Schulte G; Jonsson Fagerlund M; Eriksson LI
Acta Anaesthesiol Scand; 2012 May; 56(5):608-15. PubMed ID: 22288781
[TBL] [Abstract][Full Text] [Related]
28. Sevoflurane modulates the cancer stem cell-like properties and mitochondrial membrane potential of glioma via Ca
Han XC; Zhang YJ; Dong X; Xing QZ; Li KH; Zhang L
Life Sci; 2020 Jul; 253():117675. PubMed ID: 32360621
[TBL] [Abstract][Full Text] [Related]
29. The differential cancer growth associated with anaesthetics in a cancer xenograft model of mice: mechanisms and implications of postoperative cancer recurrence.
Iwasaki M; Zhao H; Hu C; Saito J; Wu L; Sherwin A; Ishikawa M; Sakamoto A; Buggy D; Ma D
Cell Biol Toxicol; 2023 Aug; 39(4):1561-1575. PubMed ID: 35953652
[TBL] [Abstract][Full Text] [Related]
30. Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression.
Lee J; Park SY; Lee EK; Park CG; Chung HC; Rha SY; Kim YK; Bae GU; Kim BK; Han JW; Lee HY
Clin Cancer Res; 2006 Nov; 12(21):6351-8. PubMed ID: 17085645
[TBL] [Abstract][Full Text] [Related]
31. Anti-angiogenic effects of SN38 (active metabolite of irinotecan): inhibition of hypoxia-inducible factor 1 alpha (HIF-1alpha)/vascular endothelial growth factor (VEGF) expression of glioma and growth of endothelial cells.
Kamiyama H; Takano S; Tsuboi K; Matsumura A
J Cancer Res Clin Oncol; 2005 Apr; 131(4):205-13. PubMed ID: 15583935
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesis.
Terzuoli E; Donnini S; Giachetti A; Iñiguez MA; Fresno M; Melillo G; Ziche M
Clin Cancer Res; 2010 Aug; 16(16):4207-16. PubMed ID: 20682710
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.
Li Z; Bao S; Wu Q; Wang H; Eyler C; Sathornsumetee S; Shi Q; Cao Y; Lathia J; McLendon RE; Hjelmeland AB; Rich JN
Cancer Cell; 2009 Jun; 15(6):501-13. PubMed ID: 19477429
[TBL] [Abstract][Full Text] [Related]
34. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
Carroll VA; Ashcroft M
Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202
[TBL] [Abstract][Full Text] [Related]
35. Multimodal targeting of tumor vasculature and cancer stem-like cells in sarcomas with VEGF-A inhibition, HIF-1α inhibition, and hypoxia-activated chemotherapy.
Yoon C; Chang KK; Lee JH; Tap WD; Hart CP; Simon MC; Yoon SS
Oncotarget; 2016 Jul; 7(28):42844-42858. PubMed ID: 27374091
[TBL] [Abstract][Full Text] [Related]
36. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas.
Fujiwara S; Nakagawa K; Harada H; Nagato S; Furukawa K; Teraoka M; Seno T; Oka K; Iwata S; Ohnishi T
Int J Oncol; 2007 Apr; 30(4):793-802. PubMed ID: 17332917
[TBL] [Abstract][Full Text] [Related]
37. The inhibitory effect of hypoxic cytotoxin on the expansion of cancer stem cells in ovarian cancer.
Nozawa-Suzuki N; Nagasawa H; Ohnishi K; Morishige K
Biochem Biophys Res Commun; 2015 Feb; 457(4):706-11. PubMed ID: 25619133
[TBL] [Abstract][Full Text] [Related]
38. Ibuprofen-mediated reduction of hypoxia-inducible factors HIF-1alpha and HIF-2alpha in prostate cancer cells.
Palayoor ST; Tofilon PJ; Coleman CN
Clin Cancer Res; 2003 Aug; 9(8):3150-7. PubMed ID: 12912967
[TBL] [Abstract][Full Text] [Related]
39. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo.
Said HM; Hagemann C; Staab A; Stojic J; Kühnel S; Vince GH; Flentje M; Roosen K; Vordermark D
Radiother Oncol; 2007 Jun; 83(3):398-405. PubMed ID: 17524506
[TBL] [Abstract][Full Text] [Related]
40. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
Lim CS; Kiriakidis S; Paleolog EM; Davies AH
J Vasc Surg; 2012 May; 55(5):1427-39. PubMed ID: 22277691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
